名稱 | BCR-ABL1 A337V/BaF3 |
型號 | CBP73288 |
報價 | ![]() |
特點(diǎn) | BCR-ABL1 [E255V]/BaF3,母細(xì)胞:BaF3 |
產(chǎn)品搜索
相關(guān)文章
- 一箭雙雕——IL-4R靶點(diǎn)和IL-4/IL-13雙重阻斷藥篩細(xì)胞模型
- 假病毒標(biāo)準(zhǔn)品
- IL-11藥物細(xì)胞模型簡介
- 圣誕節(jié)日,這株腫瘤細(xì)胞你的圣誕襪里,有嗎
- OSMR細(xì)胞篩選模型
- 從“腫瘤免疫療法”發(fā)展,看“單抗、CAR-T”任重而道遠(yuǎn)!
- PNAS:腫瘤細(xì)胞或可“拆用”間充質(zhì)干細(xì)胞來促進(jìn)乳腺癌復(fù)發(fā)
- PD-1/PD-L1:研發(fā)過剩還是大有可為
- 三陰性乳腺癌的一個突破口——BRCA基因檢測?
- 鑒別ATCC細(xì)胞株真?zhèn)蔚姆椒?/a>
聯(lián)系我們
電話:4008750250
號碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73288BCR-ABL1 A337V/BaF3

- 詳細(xì)內(nèi)容
CBP73288 | |
I. Introduction | |
Cell Line Name: | BCR-ABL1 [E255V]/BaF3 |
Host Cell: | Ba/F3 |
Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
II.Background | |
Presence of a BCR-ABL1 fusion gene is necessary for the pathogenesis of CML. In up to 95% of cases, a t(9;22) (q34;q11) translocation results in the BCR-ABL1 fusion gene (Faderl et al. 1999). This translocation results in the Philadephia chromosome. In rare CML cases lacking the traditional t(9;22) translocation, other translocations result in the creation of the BCR-ABL1 fusion gene, which sometimes involve multiple chromosomes. ABL1 is a tyrosine kinase, and, in normal cells, it plays a role in cellular differentiation and regulation of the cell cycle. The BCR-ABL1 fusion gene creates a constitutively active tyrosine kinase, which leads to uncontrolled proliferation. | |
III. Representative Data | |
1. WB of BCR-ABL1 [E255V]/BaF3 | |
2.Sanger of BCR-ABL1 [E255V]/BaF3 Figure 2. BCR-ABL1 E255V Figure 3. BCR-ABL1 [E255V]/BaF3 Fusion | |
3. Anti-proliferation assay Figure 4. CTG Proliferation Assay of BaF3 BCR-ABL1 E255V Cells (C1). | |